49 results
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
drug discovery in the US and Europe and launched drugs commercially More than 30 years of broad international leadership experience, including a strong … Innovation of the Bayer AG Pharmaceuticals division, and previously at Johnson & Johnson, where she held global leadership roles in drug discovery, strategy
8-K
EX-99.1
VIR
Vir Biotechnology Inc
19 Nov 19
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:05pm
joined the Vir senior leadership team in September as Chief Human Resources Officer. Over the course of the past 30 years, Mr. Rice has held several … HR leadership positions at leading technology and healthcare organizations, most recently as the Chief Human Resources Officer at the Bill and Melinda
8-K
VIR
Vir Biotechnology Inc
7 Apr 22
Departure of Directors or Certain Officers
4:06pm
as President of Europe, Canada & Partner Markets at Biogen and as a member of Biogen’s Global Leadership Team, where she was fully responsible for the regional P
8-K
EX-99.1
bwx8 2595b3pjzn
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
8-K
n9dtt98
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
S-1
EX-10.27
xm6t3fq0y43ipn
3 Sep 19
IPO registration
4:40pm
DRS/A
EX-10.27
j94jq23x3m3
7 Aug 19
Draft registration statement (amended)
12:00am
8-K
EX-99.1
2eggw5
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
x8we 31585
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
EX-99.2
qqp kom0ak
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
S-1
EX-10.26
g49d0o23yjt6177dr bo
3 Sep 19
IPO registration
4:40pm
DRS/A
EX-10.26
iqcy8n8
7 Aug 19
Draft registration statement (amended)
12:00am
8-K
EX-99.1
ld3nux q1nb7s8dz0fw
5 May 22
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results
12:00am